PTM Therapeutics, Inc.

2 known investors

PTM Therapeutics is a biotech company developing therapeutic antibodies that target Post Translational Modifications (PTMs) to create more disease-specific targets. Its pipeline includes programs for inflammatory bowel disease/ulcerative colitis and metastatic colon cancer.

Biotech